We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.92B
AUM Growth
+$705M
Cap. Flow
+$556M
Cap. Flow %
11.29%
Top 10 Hldgs %
30.88%
Holding
109
New
27
Increased
28
Reduced
31
Closed
16

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$201M
2
VTRS icon
Viatris
VTRS
+$197M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$167M
4
ELV icon
Elevance Health
ELV
+$92.3M
5
THC icon
Tenet Healthcare
THC
+$70.7M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$84.6M
2
NOW icon
ServiceNow
NOW
+$80.6M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$73.7M
4
CI icon
Cigna
CI
+$60.3M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 59.98%
2 Technology 11.1%
3 Communication Services 4.51%
4 Financials 2.87%
5 Consumer Discretionary 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PYPL icon
26
PayPal
PYPL
$49.9B
$67.7M 1.38%
892,756
+201,134
+29% +$16M
CRM icon
27
Salesforce
CRM
$154B
$64.6M 1.31%
555,808
-266,272
-32% -$30.6M
DATA
28
DELISTED
Tableau Software, Inc.
DATA
$64.4M 1.31%
+796,373
New +$63.1M
HOLX
29
DELISTED
Hologic
HOLX
$58.8M 1.19%
1,572,857
-157,527
-9% -$6.37M
A icon
30
Agilent Technologies
A
$39.6B
$57.8M 1.17%
+863,669
New +$60.5M
HCA icon
31
HCA Healthcare
HCA
$88.4B
$56.8M 1.15%
585,451
-146,556
-20% -$14.2M
VTRS icon
32
CALL
Viatris
VTRS
$20.8B
$56.7M 1.15%
+1,376,900
New +$58.7M
CME icon
33
CME Group
CME
$95.4B
$56.6M 1.15%
350,074
-42,032
-11% -$6.69M
AGIO icon
34
Agios Pharmaceuticals
AGIO
$2.08B
$55.4M 1.13%
+677,091
New +$52.3M
TWTR
35
DELISTED
Twitter, Inc.
TWTR
$54.4M 1.11%
+1,874,859
New +$55M
GOOGL icon
36
Alphabet (Google) Class A
GOOGL
$4.12T
$54.1M 1.1%
1,044,000
+189,620
+22% +$10.5M
PCRX icon
37
Pacira BioSciences
PCRX
$1.04B
$53.1M 1.08%
+1,704,608
New +$60.7M
BABA icon
38
Alibaba
BABA
$276B
$51.3M 1.04%
279,501
-80,919
-22% -$15.2M
BIDU icon
39
Baidu
BIDU
$35.7B
$51.1M 1.04%
228,822
-158,224
-41% -$39M
MYOK
40
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$46.4M 0.94%
949,911
-343,449
-27% -$17.9M
AMZN icon
41
Amazon
AMZN
$2.44T
$44.6M 0.91%
616,800
-2,520
-0.4% -$180K
XYZ
42
Block Inc
XYZ
$48.9B
$44.1M 0.9%
895,391
+157,115
+21% +$7.21M
JNCE
43
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$43M 0.87%
1,923,651
-163,573
-8% -$3.63M
TFX icon
44
Teleflex
TFX
$5.96B
$42.8M 0.87%
+167,751
New +$44.1M
ONCE
45
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$42.5M 0.86%
+637,636
New +$36.8M
BOX icon
46
Box
BOX
$4.49B
$41.7M 0.85%
2,028,739
-818,586
-29% -$17.6M
INTU icon
47
Intuit
INTU
$91.1B
$41.4M 0.84%
+238,851
New +$40.2M
DVA icon
48
DaVita
DVA
$15.5B
$41.2M 0.84%
625,003
-585,279
-48% -$43M
ECYT
49
DELISTED
Endocyte, Inc. Common Stock
ECYT
$39.4M 0.8%
4,339,244
+897,650
+26% +$4.95M
MMSI icon
50
Merit Medical Systems
MMSI
$4.82B
$38.9M 0.79%
856,794
-342,287
-29% -$15.5M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2018 Portfolio in Review

As of Q1 2018, PFM Health Sciences held 109 positions worth $4.92B, up 17% from $4.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences deployed $556M of net new capital in Q1 2018, opening 27 new positions and adding to 28 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,123,145 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $80.6M trimmed.

  • PFM Health Sciences's largest Q1 2018 buy was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
  • PFM Health Sciences added most to Elevance Health in Q1 2018, an estimated $92.3M increase.
  • PFM Health Sciences's biggest Q1 2018 reduction was ServiceNow, cutting an estimated $80.6M.
  • PFM Health Sciences fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $84.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.92B portfolio in Q1 2018.
  • PFM Health Sciences opened 27 new positions and closed 16 in Q1 2018.
  • PFM Health Sciences's portfolio value rose 17% quarter-over-quarter to $4.92B.

Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.